1Non-small Cell Lung Cancer Collaborative Group.Chemotherapy in non-small cell lung cancer; a meta-analysis using updated data on individual patients from 52 randomised clinical trials.BM J,1995,311(7 010):899
3Furuse K,Fukuoka M,Kuba M,et al.Randomized study of vinorelbine(VRB) versus vindesine (VDS) in previously untreated stage Ⅲ B orⅣ non-small-cell lung cancer(NSCLC).Ann Oncol,1996,7 (8):815
4Le chevalier T,Brisgand D,Douillard JY,et al.Randomized study of vinorelbine and cisplatin versus and cisplatin versus vinorelbine alone in advanced non-small cell lung cancer.Results of a European multicenter trial including 612 patients[J]. J Clin Oncol
5Raymond E,Chaney S,Taamma A,et a1.Oxaliplatin:A review of preclinical and clinical studies[J].Ann Oncol,1998,9(7):1053-1071.
6Monnet I,Soulie P,de Cremoux H,et al.Phase Ⅰ/Ⅱ study of escalating doses of vinorelbine in combination with oxalipating in patients with advanced non-small lung cancer[J]. J Clin Oncol, 2001;19(2):458-463.
7Antoiretee JW, Growley JJ, Balcerzak SP, et al. Randomized trial compariny cisplatin with cisplatin plus vinorelbine in the treatment of advanced nonsmall cell lung cancer; A Southwest oncology group study. J clin Oncol,1998,16: 2459.
8Monnet Ⅰ , Brienza S, Hugret F, et al. Association pour le Traitement des Tumeurs Intra Thoraciques (ATTIT). Phase Ⅱ study of oxaliplatin in poor- prognosis non - small cell lung cancer (NSCLC). Eur J Cancer, 1998,34:1124 ～ 1127.
9Monnet Ⅰ , de CH, Soulie P, et al. Oxaliplatin plus vinorelbine in advanced non- small - cell lung cancer: final results of a multicenter phase Ⅱ study. Ann Oncol (England), 2002, 13(1) :103～107.
10Kelly K, Crowley J, Bunn PA, et al. Randomized phase Ⅲ trial of paclitaxel plus carboplatin versus vinorelbine plus cisplatin in the treatment of patients with advanced non - small cell lung cancer: a Southwest Oncology Group trial. J Clin Oncol,2001,19(13) :3210 ～ 3218.
